PlantForm Corporation awarded Government of Canada contract for plant-based production of anti-ricin antibody

Ontario Industry Updates
Written By Guest User

February 8, 2016, Guelph, Ont.— PlantForm Corporation has received a Government of Canada contract for the plant-based production of an antibody being studied by Defence Research and Development Canada (DRDC) as an antidote to ricin exposure.

The contract, valued at $135,000, is for delivery of 2 grams of an anti-ricin antibody, known as hD9, produced using PlantForm’s vivoXPRESS® biopharmaceutical platform.

Ricin is highly toxic and considered a bioterrorism risk for the public as no therapeutic antibody or vaccine is currently available to counteract its deadly effects. The hD9 antibody drug candidate developed by DRDC prevents ricin from penetrating cells.

Click here for the full press release
 

Guest User
Previous

Focal Healthcare receives 510(k) clearance from the FDA for their targeted prostate biopsy device, Fusion Bx
Next

Sernova Honoured as Member of the “2016 TSX Venture 50” and Ranked #4 in Life Sciences and Clean Technologies